(Q37762502)
Statements
Dalotuzumab, a recombinant humanized mAb targeted against IGFR1 for the treatment of cancer (English)
Rossana Berardi
Riccardo Giampieri
Mario Scartozzi
Maristella Bianconi
Elena Maccaroni
scientific article published on June 2010
No description defined